The trajectory of companies tied to blockbuster drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the loss of exclusivity in key markets has introduced substantial volatility. Investors are now facing the impact of lower-cost a